Burns Matteson Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
VNIM
Burns Matteson Capital Management's LLY Position: Q2 2026 in Review
Burns Matteson Capital Management increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $330K and bringing the position to 1,163 shares worth $1.39M. The position accounts for 0.44% of the portfolio, ranked #28.
Burns Matteson Capital Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Burns Matteson Capital Management held 1,163 shares of Eli Lilly worth $1.39M as of Q2 2026.
- Burns Matteson Capital Management bought 323 Eli Lilly shares in Q2 2026, an estimated $330K.
- Eli Lilly made up 0.44% of Burns Matteson Capital Management's portfolio in Q2 2026, its #28 holding.
- Burns Matteson Capital Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.